esmolol has been researched along with Inflammatory Response Syndrome, Systemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Friese, RS; Gomez, CT; Ibrahim-Zada, I; Rhee, P; Weller, J | 1 |
| Rudiger, A | 1 |
1 review(s) available for esmolol and Inflammatory Response Syndrome, Systemic
| Article | Year |
|---|---|
Beta-block the septic heart.
Topics: Adrenergic beta-Antagonists; Animals; Cardiotonic Agents; Disease Models, Animal; Heart; Humans; Propanolamines; Propranolol; Rats; Sepsis; Systemic Inflammatory Response Syndrome | 2010 |
1 other study(ies) available for esmolol and Inflammatory Response Syndrome, Systemic
| Article | Year |
|---|---|
Inhibition of sepsis-induced inflammatory response by β1-adrenergic antagonists.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; BRCA1 Protein; Disease Models, Animal; Gene Expression Regulation; Kaplan-Meier Estimate; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Microarray Analysis; Molecular Biology; NF-kappa B p50 Subunit; Propanolamines; Random Allocation; Real-Time Polymerase Chain Reaction; Reference Values; RNA; Sepsis; Survival Analysis; Systemic Inflammatory Response Syndrome | 2014 |